Inventor · disambiguated record
Philippe Bergeron
Also filed as: BERGERON PHILIPPE
13 granted patents·8 pending applications·112 citations·filing 2005–2024
90Inventor score
Top patents by PatentIndex Score
21 records- 0192US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 0291US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 0389US7799795B2Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disordersAMGEN INC·Filed 2006·Granted Sep 21, 2010·21 cites·17 claims
- 0488US8163763B2Pyrimidine compounds, compositions and methods of useBERGERON PHILIPPE·Filed 2009·Granted Apr 24, 2012·28 cites·33 claims
- 0587US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 0681US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 0777US7271271B2Imidazolo-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted Sep 18, 2007·3 cites·14 claims
- 0876US10787446B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 29, 2020·1 cites·26 claims
- 0976US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 1075US2025115576A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1173US10392422B2Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2015·Granted Aug 27, 2019·2 cites·19 claims
- 1271US10457654B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2017·Granted Oct 29, 2019·1 cites·19 claims
- 1370US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 1468US12209075B2Pyridine-sulfonamide derivatives as sodium channel inhibitorsGENENTECH INC·Filed 2019·Granted Jan 28, 2025·0 cites·3 claims
- 1565US2024239766A13-amino piperidyl sodium channel inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1662US2024228463A1Sodium channel inhibitors and methods of designing sameGENENTECH INC·Filed 2024·Application pending·0 cites
- 1760US2021171516A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 1852US2011218211A1Azaindole inhibitors of iapGENENTECH INC·Filed 2009·Application pending·0 cites
- 1952US2020115354A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2043US2012165313A1Pyrimidine compounds, compositions and methods of useBERGERON PHILIPPE·Filed 2012·Application pending·0 cites
- 2137US2010331305A1Oxo-heterocycle fused pyrimidine compounds, compositions and methods of useGENENTECH INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Bergeron files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →